SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-11-022453
Filing Date
2011-04-15
Accepted
2011-04-15 16:05:07
Documents
3
Period of Report
2011-06-08
Effectiveness Date
2011-04-15

Document Format Files

Seq Description Document Type Size
1 v218782_def14a.htm DEF 14A 927862
2 GRAPHIC pc1.jpg GRAPHIC 158056
3 GRAPHIC pc2.jpg GRAPHIC 89426
  Complete submission text file 0001144204-11-022453.txt   1270165
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 11762769
SIC: 2834 Pharmaceutical Preparations